ΔCT Value of Amplified Refractory Mutation System Predicts Efficacy of EGFR-TKIs in Advanced Non–Small-Cell Lung Cancer: A Multi-Center Retrospective Study

ΔCT Value of Amplified Refractory Mutation System Predicts Efficacy of EGFR-TKIs in Advanced Non–Small-Cell Lung Cancer: A Multi-Center Retrospective Study

Purpose: This multi-center retrospective study determines whether the ΔCT value of the Amplified Refractory Mutation System (ARMS) predicts the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR-mutant advanced non–small-cell lung cancer (NSCLC).Patients an...

Full description

Bibliographic Details
Main Authors: Min Chen, Wenqi Huang, Dongyong Yang, Jincheng Huang, Gong Li, Xiaoqing Wang, Nanjie Xiao, Weijian Zhang, Jian Guan, Shuang Wang, Laiyu Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Molecular Biosciences
Subjects:
ΔCT
ARMS
efficacy
EGFR-TKIs
NSCLC
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.684661/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2021.684661/full

Similar Items